References
- . Banck, G., Belfrage, S., Juhlin, I., Nordström, L., Tjernström, Ö. & Toremalm, N. G.: Retrospective study of ototoxicity of gentamicin. Acta Pathol Microbiol Scand (B) 81, Suppl. 241: 54, 1973.
- . Baron, D., Drugeon, H., Nicolas, F. & Courtieu, A.: The use of tobramycin in the management of severe infections. Clinical and pharmacological data. Eur J Intensive Care Med 2: 89, 1976.
- . Blair, D. C., Fekety, R., Bruce, B., Silva, J. & Archer, G.: Therapy of Pseudomonas aeruginosa infections with tobramycin. Antimicrob Agents Chemother 8: 22, 1975.
- . Brogard, J. M., Couraux, C., Collard, M., Jahn, H. & Lavillaureix, J.: Etude de la tolérance cochléo-vestibulaire de la tobramycine chez l'homme. Nouv Presse Méd 3, Suppl. 17: 79, 1974.
- . Carmalt, E. D., Cortez, L. M. & Rosenblatt, J. E.: Clinical experience with tobramycin in the treatment of infections due to gram-negative bacilli. Am J Med Sci 271: 285, 1976.
- . Dobbs, S. M. & Mawer, G. E.: Intravenous injections of gentamicin and tobramycin without impairment of hearing. J Infect Dis 134, Suppl: 114, 1976.
- . Hawley, H. B., Lewis, R. M., Swartz, D. R. & Gump, D. W.: Tobramycin therapy of pulmonary infections in patients with cystic fibrosis. Curr Ther Res 16: 414, 1974.
- . Henriksson, N. G., Lundgren, A., Lundgren, K. & Nilsson, A.: New techniques of otoneurological diagnosis. I. Analysis of eye movements. In: Myotatic, kinesthetic and vestibular mechanisms, p. 219 (ed. A. V. S. de Renck & J. Knight). J. & A. Churchill, London 1967.
- . Henriksson, N. G., Johansson, G. & Östlund, H.: New techniques of otoneurological diagnosis. II. Vestibulospinal and postural patterns. In: Myotatic, kinesthetic and vestibular mechanisms, p. 231 (ed. A. V. S. de Renck & J. Knight). J. & A. Churchill, London 1967.
- . Henriksson, N. G., Pfaltz, C. R., Torok, N. & Rubin, W.: A synopsis of the vestibular system. Gasser & Cie, Basle 1972.
- . Hewitt, W. L.: Gentamicin: Toxicity in perspective. Postgrad Med J 50, Suppl. 7: 55, 1974.
- . Hoff, G. E., Schiøtz, P. O. & Paulsen, J.: Tobramycin treatment of Pseudomonas aeruginosa infections in cystic fibrosis. Scand J Infect Dis 6: 333, 1974.
- . Jackson, G. G. & Arcieri, G.: Ototoxicity of gentamicin in man: A survey and controlled analysis of clinical experience in the United States. J Infect Dis 124, Suppl. 130, 1971.
- . Kahlmeter, G., Hallberg, T. & Kamme, C.: Gentamicin and tobramycin in patients with various infections. I. Concentrations in serum and urinary excretion. J Antimicrob Chemother 4, Suppl. A: 37, 1978.
- . Kahlmeter, G., Hallberg, T. & Kamme, C.: Gentamicin and tobramycin in patients with various infections. II. Nephrotoxicity. J Antimicrob Chemother 4, Suppl. A: 47, 1978.
- . Madsen, P. O., Kjaer, T. B. & Mosegaard, A.: Comparison of tobramycin and gentamicin in the treatment of complicated urinary tract infections. J Infect Dis 134, Suppl. 150, 1976.
- . Mawer, G. E., Ahmad, R., Dobbs, S. M., McGough, J. G., Lucas S. B. & Tooth, J. A.: Prescribing aids for gentamicin. Br J Clin Pharmacol 1: 45, 1974.
- . Mendelson, J., Portnoy, J. & Black, M.: Safety of the bolus administration of gentamicin. Antimicrob Agents Chemother 9: 633, 1976.
- . Neu, H. C.: Tobramycin: An overview. J Infect Dis 134, Suppl. 3, 1976.
- . Neu, H. C. & Bendusch, C. L.: Ototoxicity of tobramycin: A clinical overview. J Infect Dis 134, Suppl 206, 1976.
- . Sack, K. & Friesleben, H.: Experimented Untersuchungen zur potentiellen Nephrotoxizität von Tobramycin, Gentamicin und Sisomicin. Infection 3, Suppl. 1: 40, 1976.
- . Speirs, C. F.: Tobramycin side effects–international results. Scott Med J 21: 78, 1976.
- . Uwaydah, M., Bibi, S. & Salman, S.: Therapeutic efficacy of tobramycin–a clinical and laboratory evaluation. J Antimicrob Chemother 1: 429, 1975.
- . Welles J. S., Emmerson, J. L., Gibson, W. R., Nickander, R., Owen, N. V. & Anderson, R. C.: Preclinical toxicology studies with tobramycin. Toxicol Appl Pharmacol 25: 398, 1973.